Press release
Global Grand Mal Seizure Treatment Market Projected to Surpass $2.63 Billion by 2029 with 6% Annual Growth
Grand Mal Seizure Treatment Market Share
The growing incidence of epilepsy is expected to drive the expansion of the grand mal seizure treatment market. Epilepsy, a neurological disorder characterized by recurring seizures, is often the cause for grand mal seizures which are violent in nature. The escalating prevalence necessitates improved treatments, which can be facilitated through grand mal seizure treatments. For example, the World Health Organization, a Switzerland-based public health agency of the UN, reported in February 2023 that approximately 50 million individuals globally were affected by epilepsy. This makes epilepsy among the most common neurological conditions across the globe. Annually, about 5 million individuals are diagnosed with the condition. Hence, the growing prevalence of epilepsy is spurring the growth of the grand mal seizure treatment market.
Get Your Grand Mal Seizure Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/grand-mal-seizure-treatment-global-market-report
What is the projected compound annual growth rate (CAGR) of the grand mal seizure treatment market from 2025 to 2034, and what factors influence it?
The market size for grand mal seizure treatment has seen significant expansion in the recent past. The market, which was standing at $2 billion in 2024, is projected to increase to $2.1 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. The spectacular growth during the historical period is a result of advancements in neurological comprehension, medical innovations, development of medications, evolution of seizure categorization, and progress in both legal and social advocacy.
Over the coming years, the market for grand mal seizure treatment is anticipated to witness robust growth. The market is projected to expand to $2.63 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%. This upsurge during the forecasted period can be accredited to developments in genetic research and precision medicine, implementation of telemedicine for remote healthcare, alterations in regulatory accessibility, advancements in brain imaging techniques, and a comprehensive approach to treatment. Noteworthy trends within this period incorporate global campaigns for epilepsy awareness, patient-oriented care structures, extended research in seizure genetics, communal support networks, and adoption of non-drug treatment methods.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12349&type=smp
How are the latest trends influencing the growth of the grand mal seizure treatment market?
Leading firms in the grand mal seizure treatment market are venturing into the development of new products like anti-epilepsy drugs to secure a strategic advantage. These medications, also referred to as antiepileptic drugs (AEDs) or anticonvulsants, are a group of drugs specifically crafted to manage and treat epileptic seizures and related conditions. For example, Zydus Lifesciences Limited, a pharmaceutical company based in India, launched Topiramate extended-release capsules in the U.S. market in January 2023. The company was the first to secure the final approval for this generic anti-epilepsy drug, available in strengths of USP 25 mg, 50 mg, and 100 mg. These capsules are approved for epilepsy treatment, in particular as an initial monotherapy for patients 6 years and above suffering from partial-onset or primary generalized tonic-clonic seizures, and also for preventing migraines in patients aged 12 and up.
What are the major segments of the grand mal seizure treatment market and their role in driving growth?
The grand mal seizure treatment market covered in this report is segmented -
1) By Type: Barbiturates, Hydantoin, Phenyltriazine, Iminostilbenes, Benzodiazepines, Aliphatic Carboxylic Acids, Other Types
2) By Diagnosis: Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG), Blood Tests, Computed Tomography (CT), Other Diagnosis
3) By Treatment: Antiepileptic Drugs, Surgery, Vagus Nerve Stimulation, ket*ogenic Diet, Other Treatments
4) By End Users: Academic And Research Centers, Neurological Centers, Hospitals, Other End Users
Subsegments:
1) By Barbiturates: Phenobarbital, Primidone
2) By Hydantoins: Phenytoin
3) By Phenyltriazines: Lamotrigine
4) By Iminostilbenes: Carbamazepine, Oxcabazepine
5) By Benzodiazepines: Clonazepam, Diazepam, Lorazepam
6) By Aliphatic Carboxylic Acids: Valproic Acid, Divalproex Sodium
7) By Other Types: Levetiracetam, Topiramate, Zonisamide
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12349
Which regions are key players in the growth of the grand mal seizure treatment market?
North America was the largest region in the grand mal seizure treatment market in 2024. The regions covered in the grand mal seizure treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the grand mal seizure treatment market?
Major companies operating in the grand mal seizure treatment market include Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceuticals Inc., Mylan N.V., UCB Celltech Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Cipla Inc., Apotex Inc., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Macleods Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Indoco Remedies Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12349&type=smp
What Is Covered In The Grand Mal Seizure Treatment Global Market Report?
• Market Size Forecast: Examine the grand mal seizure treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the grand mal seizure treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the grand mal seizure treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the grand mal seizure treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the grand mal seizure treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the grand mal seizure treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the grand mal seizure treatment market.
• Competitive Landscape: Review strategic developments in the grand mal seizure treatment market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Grand Mal Seizure Treatment Market Projected to Surpass $2.63 Billion by 2029 with 6% Annual Growth here
News-ID: 3896788 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
